SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-008555
Filing Date
2015-11-09
Accepted
2015-11-09 16:24:45
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-2015930x10q.htm 10-Q 931324
2 EXHIBIT 31 exhibit31193015.htm EX-31 11839
3 EXHIBIT 32 exhibit32193015.htm EX-32 7233
  Complete submission text file 0001628280-15-008555.txt   4580648

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT arna-20150930.xml EX-101.INS 788319
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20150930.xsd EX-101.SCH 47969
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arna-20150930_cal.xml EX-101.CAL 59770
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arna-20150930_def.xml EX-101.DEF 213282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20150930_lab.xml EX-101.LAB 505777
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20150930_pre.xml EX-101.PRE 313732
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 151215951
SIC: 2834 Pharmaceutical Preparations